Raltegravir (RAL) is an antiretroviral drug used in the treatment of HIV infection. It is used in combination with other medications to reduce the amount of HIV in the body and prevent it from multiplying. Raltegravir is a type of integrase inhibitor, which works by preventing HIV from inserting its genetic material into the DNA of an infected cell. It is an essential part of combination therapy for HIV and is typically used in combination with other antiretroviral drugs.
Raltegravir is a medication used along with other drugs to treat HIV infection in adults and children weighing at least 4.5 pounds (2 kilograms). It falls under a class of medications called HIV integrase inhibitors [1].
Here's a breakdown of how Raltegravir works:
- Targets HIV integrase: This enzyme is crucial for HIV to copy itself inside human cells.
- Blocks the virus: Raltegravir hinders the integrase enzyme, stopping HIV from multiplying.
- Reduces HIV in the body: By preventing HIV replication, Raltegravir helps decrease the amount of the virus in your bloodstream.
- Strengthens immune system: With a lower viral load, your immune system can function better to fight off infections.
Important things to remember about Raltegravir:
- Not a cure: While it helps manage HIV infection, Raltegravir does not cure HIV.
- Combined therapy: It's always used in combination with other HIV medications.
- Consult a doctor: It's crucial to talk to your doctor before starting Raltegravir to discuss potential side effects and interactions with other medications you might be taking.